Enasidenib Drugs Market Size, Share, Trends, Growth, Forecast Analysis Report 2019 By Product, By Application, By Segment, By Region - Global Forecast To 2025
Report ID: MN057571 | Published: Jan-2019 | No of Pages: 115
Format: pdf | Publisher: QYResearch
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
This report studies the global Enasidenib Drugs market status and forecast, categorizes the global Enasidenib Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).
The major manufacturers covered in this report
Celgene Corporation
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
50mg
100mg
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospital
Pharmacy
The study objectives of this report are:
To analyze and study the global Enasidenib Drugs capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Enasidenib Drugs manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Enasidenib Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Enasidenib Drugs Manufacturers
Enasidenib Drugs Distributors/Traders/Wholesalers
Enasidenib Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Enasidenib Drugs market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents
Table of Contents
Global Enasidenib Drugs Market Research Report 2018
1 Enasidenib Drugs Market Overview
1.1 Product Overview and Scope of Enasidenib Drugs
1.2 Enasidenib Drugs Segment by Type (Product Category)
1.2.1 Global Enasidenib Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Enasidenib Drugs Production Market Share by Type (Product Category) in 2017
1.2.3 50mg
1.2.3 100mg
1.3 Global Enasidenib Drugs Segment by Application
1.3.1 Enasidenib Drugs Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Enasidenib Drugs Market by Region (2013-2025)
1.4.1 Global Enasidenib Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Enasidenib Drugs (2013-2025)
1.5.1 Global Enasidenib Drugs Revenue Status and Outlook (2013-2025)
1.5.2 Global Enasidenib Drugs Capacity, Production Status and Outlook (2013-2025)
2 Global Enasidenib Drugs Market Competition by Manufacturers
2.1 Global Enasidenib Drugs Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Enasidenib Drugs Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Enasidenib Drugs Production and Share by Manufacturers (2013-2018)
2.2 Global Enasidenib Drugs Revenue and Share by Manufacturers (2013-2018)
2.3 Global Enasidenib Drugs Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Enasidenib Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Enasidenib Drugs Market Competitive Situation and Trends
2.5.1 Enasidenib Drugs Market Concentration Rate
2.5.2 Enasidenib Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Enasidenib Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Enasidenib Drugs Capacity and Market Share by Region (2013-2018)
3.2 Global Enasidenib Drugs Production and Market Share by Region (2013-2018)
3.3 Global Enasidenib Drugs Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Enasidenib Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Enasidenib Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Enasidenib Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Enasidenib Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Enasidenib Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Enasidenib Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Enasidenib Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Enasidenib Drugs Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Enasidenib Drugs Consumption by Region (2013-2018)
4.2 North America Enasidenib Drugs Production, Consumption, Export, Import (2013-2018)
4.3 Europe Enasidenib Drugs Production, Consumption, Export, Import (2013-2018)
4.4 China Enasidenib Drugs Production, Consumption, Export, Import (2013-2018)
4.5 Japan Enasidenib Drugs Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Enasidenib Drugs Production, Consumption, Export, Import (2013-2018)
4.7 India Enasidenib Drugs Production, Consumption, Export, Import (2013-2018)
5 Global Enasidenib Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Enasidenib Drugs Production and Market Share by Type (2013-2018)
5.2 Global Enasidenib Drugs Revenue and Market Share by Type (2013-2018)
5.3 Global Enasidenib Drugs Price by Type (2013-2018)
5.4 Global Enasidenib Drugs Production Growth by Type (2013-2018)
6 Global Enasidenib Drugs Market Analysis by Application
6.1 Global Enasidenib Drugs Consumption and Market Share by Application (2013-2018)
6.2 Global Enasidenib Drugs Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Enasidenib Drugs Manufacturers Profiles/Analysis
7.1 Celgene Corporation
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Enasidenib Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Celgene Corporation Enasidenib Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
8 Enasidenib Drugs Manufacturing Cost Analysis
8.1 Enasidenib Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Enasidenib Drugs
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Enasidenib Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Enasidenib Drugs Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Enasidenib Drugs Market Forecast (2018-2025)
12.1 Global Enasidenib Drugs Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Enasidenib Drugs Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Enasidenib Drugs Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Enasidenib Drugs Price and Trend Forecast (2018-2025)
12.2 Global Enasidenib Drugs Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Enasidenib Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Enasidenib Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Enasidenib Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Enasidenib Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Enasidenib Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Enasidenib Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Enasidenib Drugs Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Enasidenib Drugs Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
